Vol. 3 No. 02 (2019)
Original Article

Efficacy of Azithromycin versus Ceftriaxone for the treatment of uncomplicated typhoid fever in children

Ishrat Jahan
Asst. Registrar
Mohammad Enamul Karim
Registrar, National Heart Foundation Hospital and Research Institute, Mirpur. Dhaka
Md. Kamrul Ahsan Khan
Assistant Professor Neonatology. Sheikh Sayera Khatun Medical College. Gopalgonj
Khan Nizamuddin
Professor and Head, Department of Paediatrics, Shaheed Mansur Ali Medical College & Hospital, Dhaka
Habiba Anjuman
Asst. Registrar, Uttara Adhunik Medical College and Hospital, Dhaka
Ferdous ara
Registrar, Uttara Adhunik Medical College and Hospital, Dhaka

Published 21-09-2021

Keywords

  • Typhoid fever,
  • Azithromycin,
  • Ceftriaxone

How to Cite

1.
Efficacy of Azithromycin versus Ceftriaxone for the treatment of uncomplicated typhoid fever in children. Planet (Barisal) [Internet]. 2021 Sep. 21 [cited 2024 Nov. 25];3(02):10. Available from: https://bdjournals.org/index.php/planet/article/view/33

Abstract

Introduction: Typhoid fever is a global major public health problem. Its incidence is high inchildren from both low & high socio economic groups. Antimicrobial therapy is important in itsmanagement. MDR case has begun to appear around 1990. Ciprofloxacin resistance was firstreported in Bangladesh in 2000.6 Ceftriaxone is still highly effective, but costly and requiresparental administration and cumbersome to children. So an effective, safe and alternative drugin the treatment of typhoid fever is always a demand. Azithromycin is a potential drug intreatment of typhoid fever because of its high intracellular penetration and long half-life (72hours). Aims & Objectives- To determine the efficacy of Azithromycin versus Ceftriaxone in thetreatment of uncomplicated typhoid fever. Methodology- This RCT was conducted in theDepartment of Paediatrics of Shaheed Mansur Ali Medical College & Hospital, Dhaka; over aperiod of 6 (six) months. A total of 35 cases (Azithromycin) & 35 controls (Ceftriaxone) wereincluded in this study. Results- Most respondents in both groups were ≤ 5 years’ age. Mean agewas 5.53±3.41years for cases and 5.53±2.55 years for controls (p-0.146). In both groups M:Fratio was 1:1. Mean weight was 17.30±6.13 kg for cases and 17.17± 6.55kg for control (p0.798). Most respondents were from middle socio-economic classes (p-0.083). Clinicalpresentation was similar in both groups. A quarter of participants in each group (25.7% &22.9%) gave history of receiving antibiotic before admission. ‘Widal test’ was negative in 2.9%of cases and 5.7% of Control (p-0.328). S. typhi. was present in blood culture in majority casesexcept, 14.3% in Azithromycin and 8.6% in Ceftriaxone group yelled ‘no growth’ (p-0.241).Repeat blood culture on day10, showed no growth in all the 54 culture positive cases. Childrenof Azithromycin group was afebrile within 6 days of starting treatment, mean 4.88± 0.40 daysand in Ceftriaxone group most (97.1%) required ≥7 days, mean 7.14±0.42 days (p-0.001). Asdefervescence was achieved before the completion of treatment, both the groups weredischarged in due time, i.e. Azithromycin group after 7 days and Ceftriaxone group after 10days. Conclusion- Treatment of uncomplicated typhoid fever with Azithromycin is relatively easier; takes shorter time to achieve defervescence and the duration of treatment is also shorter in comparison to Ceftriaxone.

References

  1. Harish BN, Menezes GA, Sarangapani K, Parija SC. A case report & review of literature ciprofloxacin resistant salmonella enteric serover typhi in India. j Infect Developing countries 2008; 2:324-27.
  2. Crump JA, Luby SP, Minpz DE. The global burden of typhoid fever. Bulletin of the Who Health Organization 2004, 82: 346-53.
  3. Black RE, Cisneros L, Levine MM, Banfi A, Lobos H, Rodriguez H. Case control study to identify risk factor for paediatric endemic typhoid fever in Santiago, Chile. Bull WHO, 1985; 63:899-904.
  4. Ferrera KP, Bonasang ES. Azithromycin versus first line antibiotics in the therapeutic management of documented case of typhoid fever. Phil j Microbiol Infect Dis 2004; 33: 163-68.
  5. Girgis NI, Butler T, Frenck RW, Sultan Y, Brown FM, Tribble D and Khakhria R. Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance. Antimicrobial Agent and Chemotherapy, 1999; 43: 1441-44.
  6. Rahman AKMM, Ahmad M, Begum RS, Ghosh AK, Hossain MZ. Multidrug resistant typhoid fever in children. J Dhaka Med Coll. 2008; 17: 121-26.
  7. Frenck RW Jr., Nakhla I, Sultan Y, Bassily SB, Girgis YF, David J, et al. M Azithromycin versus Ceftriaxone for the Treatment of Uncomplicated Typhoid Fever in Children. Clinical Infectious Diseases 2000; 31:1134-38.
  8. Frenck RW Jr. Mansour A, Nakhla I, Sultan Y, Putnams, Wierzba T, et al. Short course Azithromycin for the treatment of uncomplicated typhoid fever in children and adolescents. Clin infect Dis 2004; 38:951-7.
  9. Shah D. Role of Azithromycin in enteric fever. Indian Pediatr 2009; 46:51-52.
  10. Aggarwal A, Ghosh A, Gomber S, Mtra M, Prikh AO. Efficacy and Safety of Azithromycin for Uncomplicated Typhoid Fever: An Open Label Noncomparative Study. Indian Pediatr 2011; 48:553-56.
  11. Khan KA, Biswas BC, Hossain I, Jahan I, Banu NA, Shamshad IA, Begum HA. Drug Response in Childhood Typhoid Fever: A Comparative Analysis of Ciprofloxacine, Ceftriaxone and Azithromycin. Sir Salimullah Med Coll J. 2012; 20: 36-44.
  12. Khan KA, Rahman M, Nahar N, Mosleh T, Alam J, Banu NA, Hoque MM, Dutta S. A Comparative Analysis of Ceftriaxone and Azithromycin in the Treatment of Uncomplicated Typhoid Fever in Children. ICMH Journal. 2016; 7(1):33-39.